Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

Prognostic value of SUVmax in regional lymph node equal to or greater than SUVmax in the primary tumor on pre-therapy 18F-FDG PET/CT for patients with stage III non-small cell lung cancer

Bingfeng Tang, Nathan Hall, John Grecula and Lai Wei
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 127;
Bingfeng Tang
1The Ohio State University Wexner Medical Center, Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Hall
1The Ohio State University Wexner Medical Center, Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Grecula
1The Ohio State University Wexner Medical Center, Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lai Wei
1The Ohio State University Wexner Medical Center, Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 55 no. supplement 1 127

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 5, 2014.

Copyright & Usage 
© 2014

Author Information

  1. Bingfeng Tang1,
  2. Nathan Hall1,
  3. John Grecula1 and
  4. Lai Wei1
  1. 1The Ohio State University Wexner Medical Center, Columbus, OH

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to April 2025

AbstractFullPdf
Dec 2014200
Jan 2015700
Feb 2015100
Apr 2015100
Jul 2015100
Aug 2015400
Sep 2015800
Oct 2015400
Nov 2015100
Dec 2015200
Jan 2016100
Feb 2016200
May 2016800
Jul 2016100
Sep 2016100
Nov 2016200
Apr 2017300
May 2017500
Jun 2017100
Jul 2017200
Nov 2017100
May 2018100
Aug 2018100
Sep 2018600
Oct 2018400
Nov 2018300
Dec 2018500
Jan 2019200
Mar 2019100
May 2019300
Jun 2019500
Jul 2019100
Aug 2019100
Sep 2019200
Oct 2019300
Nov 2019500
Dec 2019500
Jan 2020400
Feb 2020800
Mar 20201700
Apr 20201800
May 2020400
Jun 2020300
Jul 2020400
Aug 20203400
Sep 20203100
Oct 20201300
Nov 20201800
Dec 20201500
Jan 2021600
Feb 20212400
Mar 20212900
Apr 20214600
May 2021800
Jun 2021300
Jul 20211900
Aug 20213900
Sep 20211600
Oct 20211200
Nov 20218300
Dec 20214000
Jan 20227400
Feb 20221800
Mar 20224300
Apr 20221200
May 20222100
Jun 2022400
Aug 2022300
Sep 2022200
Oct 2022100
Nov 2022300
Jan 2023400
Feb 2023100
Mar 2023100
Apr 2023100
May 2023400
Jun 2023200
Jul 2023100
Aug 2023800
Sep 2023500
Oct 2023200
Nov 2023400
Dec 2023200
Jan 2024300
Feb 2024200
Mar 2024100
Apr 2024400
May 2024500
Jun 2024600
Jul 2024100
Aug 2024800
Sep 20241800
Oct 2024400
Nov 2024400
Dec 2024600
Feb 2025300
Mar 2025200
Apr 2025600
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic value of SUVmax in regional lymph node equal to or greater than SUVmax in the primary tumor on pre-therapy 18F-FDG PET/CT for patients with stage III non-small cell lung cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prognostic value of SUVmax in regional lymph node equal to or greater than SUVmax in the primary tumor on pre-therapy 18F-FDG PET/CT for patients with stage III non-small cell lung cancer
Bingfeng Tang, Nathan Hall, John Grecula, Lai Wei
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 127;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prognostic value of SUVmax in regional lymph node equal to or greater than SUVmax in the primary tumor on pre-therapy 18F-FDG PET/CT for patients with stage III non-small cell lung cancer
Bingfeng Tang, Nathan Hall, John Grecula, Lai Wei
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 127;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • A regression model to predict tumor cellularity in patients with prostate cancer and low FDG uptake
  • Prediction of Response to Neoadjuvant Chemotherapy in Osteosarcoma using Dual-phase 18F-FDG PET/CT
  • Intratumoral metabolic heterogeneity can be useful to select patients for radiotherapy dose-escalation in stage III non-small cell lung cancer
Show more Oncology: Clinical Diagnosis

INTEGRATED Session: PET Predictors of Lung Cancer Prognosis

  • Predictive value of asphericity of pretherapeutic FDG uptake in NSCLC
  • 18F-FLT PET/CT tumor heterogeneity is an effective biomarker in the diagnosis and staging of lung cancer
  • TIGAR is correlated with maximal standardized uptake value on FDG-PET and survival in non-small cell lung cancer
Show more INTEGRATED Session: PET Predictors of Lung Cancer Prognosis

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire